MY006Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy

Sponsor:

Mabylon AG

Code:

NCT07287033

Conditions

Peanut Allergies

Eligibility Criteria

Sex: All

Age: 12 - 55

Healthy Volunteers: Accepted

Interventions

MY006 Low Dose

MY006 Mid Dose

MY006 High Dose

MY006 Selected Dose

Placebo (Vehicle)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-26. This information was provided to ClinicalTrials.gov by Mabylon AG on 2026-08-25.